(Total Views: 365)
 Posted On: 07/21/2021 11:26:00 AM 
  
		  		    Post#  of 114		    
			
		      
  
	$SRNE News Article - Sorrento Announces Dosing of COVID-19 Patients in Phase 2 Clinical Trial for COVIDROPS, a Highly Potent Neutralizing Antibody Against SARS-CoV-2 Including Delta and Alpha Variants of Concern, in an At-Home Outpatient Setting in United Kingdom https://marketwirenews.com/news-releases/sorr...13650.html 
 	
 
 (0)
(0) (0)
(0)
       My Twitter:  WhyteStocks  
  
    
      
    
   
      			












